4//SEC Filing
Brown Willie L. Jr. 4
Accession 0000899243-19-017615
CIK 0001629137other
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 4:01 PM ET
Size
8.7 KB
Accession
0000899243-19-017615
Insider Transaction Report
Form 4
Brown Willie L. Jr.
Director
Transactions
- Award
Restricted Stock Units
2019-06-18+4,800→ 4,800 total→ Common Stock (4,800 underlying) - Award
Stock Option (Right to Buy)
2019-06-18+7,500→ 7,500 totalExercise: $56.30Exp: 2029-06-17→ Common Stock (7,500 underlying)
Footnotes (2)
- [F1]The shares subject to this option shall vest and become exercisable in equal monthly installments over a period of 12 months following June 18, 2019, for 11 months and the remaining 1/12th on the earlier of (i) June 18, 2020 or (ii) the Issuer's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Issuer's Board of Directors. This option is subject to full acceleration of vesting with respect to all then-unvested shares upon the consummation of a Sale Event (as defined in the Issuer's 2015 Stock Option and Incentive Plan, as amended).
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in a single installment on the earlier of (i) June 18, 2020, or (ii) the Issuer's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Issuer's Board of Directors. The shares of Common Stock underlying the RSUs are subject to full acceleration of vesting with respect to all then-unvested shares upon the consummation of a Sale Event (as defined in the Issuer's 2015 Stock Option and Incentive Plan, as amended).
Documents
Issuer
Global Blood Therapeutics, Inc.
CIK 0001629137
Entity typeother
Related Parties
1- filerCIK 0001650411
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 4:01 PM ET
- Size
- 8.7 KB